KeyGene announced that it has licensed its proprietary Sequence-Based Genotyping (SBG) methods to Bayer’s Crop Science division. Under the agreement, Bayer’s Crop Science division
obtains a non-exclusive licence for the in-house use of the SBG technology for crop improvement. SBG methods are highly cost-effective to identify and score thousands of DNA markers. The use of SBG accelerates genetic improvement of crops with novel traits, thereby providing solutions to feed the world in a sustainable way. Financial terms of the agreement were not disclosed.
 
"KeyGene is delighted with licensing its global SBG patent portfolio to Bayer’s Crop Science division, an innovation-driven enterprise with competencies in the field of agriculture", said Michiel van Eijk, CSO of KeyGene. "This licence agreement with Bayer’s Crop Science division supports our shared commitment to crop improvement and meeting the challenges of sustainable food supply."